ADA Levels in Body Fluids as the Preferred Test to Rule Out Tuberculosis in Limited-resource Settings: Data from a Tertiary Care Hospital in Northern India
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In clinical practice, the diagnosis of tuberculosis (TB) continues to be a challenge. The goal of this study was to evaluate the reliability and impact of adenosine deaminase (ADA) enzyme testing as a biochemical marker in the continued management of suspected tuberculosis in a limited resource setting hospital. The retrospective data were collected from 2018 to 2021 and comprised the results of all ADA test assays done in the laboratory. All types of body fluids received for ADA testing were analyzed. Over the course of two years, 1461 samples for ADA assay testing were received. The average age of the study population was 56.69±11.7 years, with males accounting for the majority of the subjects (55.72%). Pleural fluid (N=817, 55.92%) was the most common type of sample received for the ADA assay. 114 (13.95%) of the 817 pleural fluid samples were found to be positive. A survey was conducted to obtain physician’s response regarding reliability on ADA testing. 100% of them reported the supportive role of ADA levels in the workup of patients with suspected tuberculosis. In a limited resource setting, the ADA test, in conjunction with clinical and other laboratory findings, can help physicians to initiate early treatment in hospitals for the benefit of patients.
Abstract
In clinical practice, the diagnosis of tuberculosis (TB) continues to be a challenge. The goal of this study was to evaluate the reliability and impact of adenosine deaminase (ADA) enzyme testing as a biochemical marker in the continued management of suspected tuberculosis in a limited resource setting hospital. The retrospective data were collected from 2018 to 2021 and comprised the results of all ADA test assays done in the laboratory. All types of body fluids received for ADA testing were analyzed. Over the course of two years, 1461 samples for ADA assay testing were received. The average age of the study population was 56.69±11.7 years, with males accounting for the majority of the subjects (55.72%). Pleural fluid (N=817, 55.92%) was the most common type of sample received for the ADA assay. 114 (13.95%) of the 817 pleural fluid samples were found to be positive. A survey was conducted to obtain physician’s response regarding reliability on ADA testing. 100% of them reported the supportive role of ADA levels in the workup of patients with suspected tuberculosis. In a limited resource setting, the ADA test, in conjunction with clinical and other laboratory findings, can help physicians to initiate early treatment in hospitals for the benefit of patients.
참고문헌 (28)
- "TB in India - Elimination, National Plans, COVID" (2022)[URL]
- "Lakshadweep, district Budgam in JK declared TB free" (2021)[URL]
- Subinay D, "Adenosine deaminase and its isoenzyme as a diagnostic marker in tubercular pleural effusion", J Drug Del Ther, 4, pp.18~21 (2014)[DOI]
- Shadia K, "Adenosine deaminase assay in different body fluids for the diagnosis of tubercular infection", Am J Biomed Sci, 3, pp.49~54 (2015)[DOI]
- KoffA, "Diagnosing peritoneal tuberculosis", BMJ Case Rep, 13, pp.e233131~ (2020)[DOI]
- Flinn AM, "Adenosine deaminase deficiency : a review", Orphanet J Rare Dis, 13, pp.65~ (2018)[DOI]
- Moens L, "Human adenosine deaminase 2 deficiency : a multi-faceted inborn error of immunity", Immunol Rev, 287, pp.62~72 (2019)[DOI]
- Kaya S, "Adenosine deaminase activity in serum of patients with hepatitis-a useful tool in monitoring clinical status", J Microbiol Immunol Infect, 40, pp.288~292 (2007)
- Moreno E, "Molecular evidence of adenosine deaminase linking adenosine A2A receptor and CD26 proteins", Front Pharmacol, 9, pp.106~ (2018)[DOI]
- Borea PA, "Pharmacology of adenosine receptors : the state of the art", Physiol Rev, 98, pp.1591~1625 (2018)[DOI]
- Haskó G, "Adenosine metabolism, immunity and joint health", Biochem Pharmacol, 151, pp.307~313 (2018)[DOI]
- Barua R, "Adenosine deaminase in diagnosis of tuberculosis : a review", AKMMC J, 5, pp.43~48 (2014)[DOI]
- Tiruviluamala P, "Tuberculosis", Annu Rev Public Health, 23, pp.403~426 (2002)[DOI]
- Mishra OP, "Adenosine deaminase activity and lysozyme levels in children with tuberculosis", J Trop Pediatr, 46, pp.175~178 (2000)[DOI]
- Golden MP, "Extrapulmonary tuberculosis : an overview", Am Fam Physician, 72, pp.1761~1768 (2005)
- Krenke R, "Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis", Curr Opin Pulm Med, 16, pp.367~375 (2010)[DOI]
- Flinn AM, "Adenosine deaminase deficiency : a review", Orphanet J Rare Dis, 13, pp.65~ (2018)[DOI]
- Giblett ER, "Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity", Lancet, 2, pp.1067~1069 (1972)[DOI]
- Burgess LJ, "Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy", Thorax, 50, pp.672~674 (1995)[DOI]
- Jiménez Castro D, "Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions", Eur Respir J, 21, pp.220~224 (2003)[DOI]
- Gupta BK, "Sensitivity, specificity, negative and positive predictive values of adenosine deaminase in patients of tubercular and non-tubercular serosal effusion in India", J Clin Med Res, 2, pp.121~126 (2010)[DOI]
- Salmanzadeh S, "Diagnostic value of serum adenosine deaminase(ADA)level for pulmonary tuberculosis", Jundishapur J Microbio, 8, pp.e21760~ (2015)[DOI]
- Forouhi NG, "CVD risk factors and ethnicity-a homogeneous relationship?", Atheroscler Suppl, 7, pp.11~19 (2006)[DOI]
- Corbo RM, "Genetic studies on the Senegal population. II. Polymorphisms of the plasma proteins F13A, F13B, ORM1, AHSG, C6, C7, and APOC2", Hum Biol, 66, pp.885~903 (1994)
- Klein SL, "Sex differences in immune responses", Nat Rev Immunol, 16, pp.626~638 (2016)[DOI]
- Fischer J, "Sex differences in immune responses to infectious diseases", Infection, 43, pp.399~403 (2015)[DOI]
- Gebhard C, "Impact of sex and gender on COVID-19 outcomes in Europe", Biol Sex Differ, 11, pp.29~ (2020)[DOI]
- Eshima N, "Age-specific sex-related differences in infections : a statistical analysis of national surveillance data in Japan", PLoS One, 7, pp.e42261~ (2012)[DOI]